Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing
59:50
Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality Testing
1:01:18
2022 Jan26 Webinar
59:12
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms and Primers
1:07:13
Bringing stem cells to patients: Treating age-related blindness
24:00
Invivoscribe Virtual 25th EHA Annual Congress - Prof. Sara Galimberti
17:18
Boost Your Bone Density with These 6 Life-Changing Tips
1:02:19
Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies
1:33:01